KURA ONCOLOGY, INC. Increase (Decrease) in Accounts Payable
KURA ONCOLOGY, INC. (KURA) reported Increase (Decrease) in Accounts Payable of -$2.62 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-12
- KURA ONCOLOGY, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$4.65M.
- KURA ONCOLOGY, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $2.03M, a 35.50% decline year-over-year.
- KURA ONCOLOGY, INC. increase (decrease) in accounts payable for the quarter ending 2025-06-30 was -$2.91M.
- KURA ONCOLOGY, INC. increase (decrease) in accounts payable for the quarter ending 2025-03-31 was $3.14M.
- KURA ONCOLOGY, INC. increase (decrease) in accounts payable for fiscal 2025 was $4.50M.
- KURA ONCOLOGY, INC. increase (decrease) in accounts payable for fiscal 2024 was -$1.63M.
- KURA ONCOLOGY, INC. increase (decrease) in accounts payable for fiscal 2023 was -$924.00K.
- KURA ONCOLOGY, INC. increase (decrease) in accounts payable for fiscal 2014 was $2.05K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 43 month | Increase (Decrease) in Accounts Payable 46 month | Increase (Decrease) in Accounts Payable 49 month | Increase (Decrease) in Accounts Payable 52 month | Increase (Decrease) in Accounts Payable 55 month | Increase (Decrease) in Accounts Payable 58 month | Increase (Decrease) in Accounts Payable 62 month | Increase (Decrease) in Accounts Payable 64 month | Increase (Decrease) in Accounts Payable 67 month | Increase (Decrease) in Accounts Payable 70 month | Increase (Decrease) in Accounts Payable 73 month | Increase (Decrease) in Accounts Payable 76 month | Increase (Decrease) in Accounts Payable 79 month | Increase (Decrease) in Accounts Payable 82 month | Increase (Decrease) in Accounts Payable 85 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$2.62M 10-Q · filed 2026-08-12 | |||||||||||||||||
| 2026-03-31 | $2.03M 10-Q · filed 2026-05-12 | ||||||||||||||||||
| 2025-12-31 | $4.50M 10-K · filed 2026-03-05 | ||||||||||||||||||
| 2025-06-30 | -$2.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $235.00K 10-Q · filed 2026-08-12 | |||||||||||||||||
| 2025-03-31 | $3.14M 10-Q · filed 2026-05-12 | ||||||||||||||||||
| 2024-12-31 | -$1.63M 10-K · filed 2026-03-05 | ||||||||||||||||||
| 2023-12-31 | -$924.00K 10-K · filed 2026-03-05 | ||||||||||||||||||
| 2014-12-31 | -$8.28K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$5.75K derived: sum of 2 quarters · filed 2015-02-27 | $1.69K derived: sum of 3 quarters · filed 2015-02-27 | $2.05K 10-K · filed 2015-02-27 | $2.40K 10-K · filed 2015-02-27 | ||||||||||||||
| 2014-09-30 | $2.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $9.97K derived: sum of 2 quarters · filed 2014-11-14 | $10.33K 10-Q · filed 2014-11-14 | $10.03K derived: sum of 4 quarters · filed 2015-02-27 | $10.68K 10-Q · filed 2014-11-14 | ||||||||||||||
| 2014-06-30 | $7.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $7.80K 10-Q · filed 2014-08-14 | $7.50K derived: sum of 3 quarters · filed 2015-02-27 | $7.98K derived: sum of 4 quarters · filed 2015-02-27 | $8.15K 10-Q · filed 2014-08-14 | ||||||||||||||
| 2014-03-31 | $363.00 10-Q · filed 2014-05-15 | $63.00 derived: sum of 2 quarters · filed 2015-02-27 | $538.00 derived: sum of 3 quarters · filed 2015-02-27 | -$5.58K derived: sum of 4 quarters · filed 2015-02-27 | $713.00 10-Q · filed 2014-05-15 | ||||||||||||||
| 2013-12-31 | -$300.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $175.00 derived: sum of 2 quarters · filed 2015-02-27 | -$5.94K derived: sum of 3 quarters · filed 2015-02-27 | -$1.50K 10-K · filed 2015-02-27 | $350.00 10-K · filed 2014-03-31 | ||||||||||||||
| 2013-09-30 | $475.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$5.64K derived: sum of 2 quarters · filed 2014-11-14 | -$1.20K 10-Q · filed 2014-11-14 | $17.00 derived: sum of 4 quarters · filed 2014-11-14 | $650.00 10-Q · filed 2013-11-14 | ||||||||||||||
| 2013-06-30 | -$6.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$1.68K 10-Q · filed 2014-08-14 | -$458.00 derived: sum of 3 quarters · filed 2014-08-14 | $0.00 derived: sum of 4 quarters · filed 2014-08-14 | $175.00 10-Q · filed 2013-08-14 | ||||||||||||||
| 2013-03-31 | $4.44K 10-Q · filed 2014-05-15 | $5.66K derived: sum of 2 quarters · filed 2014-05-15 | $6.12K derived: sum of 3 quarters · filed 2014-05-15 | $2.47K derived: sum of 4 quarters · filed 2014-05-15 | $6.29K 10-Q · filed 2013-05-15 | ||||||||||||||
| 2012-12-31 | $1.22K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.68K derived: sum of 2 quarters · filed 2014-03-31 | -$1.97K derived: sum of 3 quarters · filed 2014-03-31 | -$1.08K 10-K · filed 2014-03-31 | $1.85K 10-K · filed 2013-03-28 | ||||||||||||||
| 2012-09-30 | $458.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$3.18K derived: sum of 2 quarters · filed 2013-11-14 | -$2.29K 10-Q · filed 2013-11-14 | -$1.97K derived: sum of 4 quarters · filed 2013-11-14 | $633.00 10-Q · filed 2012-11-14 | ||||||||||||||
| 2012-06-30 | -$3.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$2.75K 10-Q · filed 2013-08-14 | -$2.42K derived: sum of 3 quarters · filed 2013-08-14 | -$2.13K derived: sum of 4 quarters · filed 2013-08-14 | $175.00 10-Q · filed 2012-08-14 | ||||||||||||||
| 2012-03-31 | $889.00 10-Q · filed 2013-05-15 | $1.22K derived: sum of 2 quarters · filed 2013-05-15 | $1.51K derived: sum of 3 quarters · filed 2013-05-15 | $511.00 derived: sum of 4 quarters · filed 2013-05-15 | $3.82K 10-Q · filed 2012-05-15 | ||||||||||||||
| 2011-12-31 | $329.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $626.00 derived: sum of 2 quarters · filed 2013-03-28 | -$378.00 derived: sum of 3 quarters · filed 2013-03-28 | $762.00 10-K · filed 2013-03-28 | $2.93K 10-K · filed 2012-03-30 | ||||||||||||||
| 2011-09-30 | $297.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$707.00 derived: sum of 2 quarters · filed 2012-11-14 | $433.00 10-Q · filed 2012-11-14 | $1.97K derived: sum of 4 quarters · filed 2012-11-14 | $2.50K 10-Q · filed 2011-11-14 | ||||||||||||||
| 2011-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $136.00 10-Q · filed 2012-08-14 | $1.67K derived: sum of 3 quarters · filed 2012-08-14 | $2.03K derived: sum of 4 quarters · filed 2012-08-14 | $2.20K 10-Q · filed 2011-08-15 | ||||||||||||||
| 2011-03-31 | $1.14K 10-Q · filed 2012-05-15 | $2.67K derived: sum of 2 quarters · filed 2012-05-15 | $3.03K derived: sum of 3 quarters · filed 2012-05-15 | ||||||||||||||||
| 2010-12-31 | $1.53K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $1.89K derived: sum of 2 quarters · filed 2012-03-30 | $1.89K 10-K · filed 2012-03-30 | ||||||||||||||||
| 2010-09-30 | $356.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $356.00 10-Q · filed 2011-11-14 | |||||||||||||||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |